Mr. Zheng's practice areas include securities and capital markets, corporate M&As, private equity financing, venture capital deals and cross-border investments. Mr. Zheng has helped companies to list on the main boards of the Mainland and Hong Kong Stock Exchanges and provided legal services to listed companies undergoing restructuring, refinancing, takeovers and other processes.

Matters that Mr. Zheng has been involved with include:

- The Shanghai Stock Exchange IPO of Sinosoft Company Limited.

- The ChiNext IPO of Jianan Electronics.

- The SSE STAR Market IPO of Changchun BCHT Biotechnology Co., Ltd.

- The ChiNext IPO of Sanbo Hospital Management Group Limited

- The Hong Kong IPO of 7Road Holdings Limited.

- The ChiNext IPO of InTec PRODUCTS, INC.

- The Beijing Stock Exchange IPO of Beijing Yunxingyu Traffic Technology Ltd.

- The ChiNext IPO of Northlab (Shenyang) Inc., Ltd.

- The material asset restructuring of CITIC Securities.

- The material asset restructuring of Hanjia Design Group Co Ltd.

- The material asset restructuring of Liaoning Hongyang Energy Co Ltd.

- The private placement of Meijin Energy Co Ltd.

He also provides legal services to the following clients: Vanke Co Ltd, China Investment Corporation, Foxconn Industrial Internet, P&G, Eastone Century Technology Co Ltd, Kangxin New Materials Co Ltd, YanTai Yuancheng Gold Co Ltd, Yintai Gold Co Ltd, Zhuhai Hokai Medical Instruments Co Ltd, Bluesail Medical Co Ltd, Chengzhi Co Ltd, Huangtai Liquor Co Ltd, Harbin Pharmaceutical Group Holding Co Ltd, Dalian Energas Gas-System Co Ltd, Tianma Group, GF Securities, Chenming Group, Asia Link Technology, and Insigma Technology.

Before joining Lifang & Partners, Mr. Zheng worked in the Chinese Ministry of Foreign Affairs, the World Bank and Akin Gump Sirauss Hauer & Feld LLP.

Member of the Expert Committee on M&As and Listed Company Reorganizations under the China Securities Regulatory Commission

Listed expert in the Public-Private Partnership Expert Database